Duong VH - Search Results

1

Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failure.

Jaglal MV, Duong VH, Bello CM, Al Ali NH, Padron E, Fernandez HF, List AF, Lancet JE, Komrokji RS. Jaglal MV, et al. Among authors: duong vh. Leuk Res. 2014 Apr;38(4):443-6. doi: 10.1016/j.leukres.2013.12.010. Epub 2013 Dec 25. Leuk Res. 2014. PMID: 24439565

2

A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leukemias.

Lancet JE, Duong VH, Winton EF, Stuart RK, Burton M, Zhang S, Cubitt C, Blaskovich MA, Wright JJ, Sebti S, Sullivan DM. Lancet JE, et al. Among authors: duong vh. Clin Cancer Res. 2011 Mar 1;17(5):1140-6. doi: 10.1158/1078-0432.CCR-10-1878. Epub 2011 Jan 13. Clin Cancer Res. 2011. PMID: 21233404 Free PMC article. Clinical Trial.

3

Phase II pilot study of oral dasatinib in patients with higher-risk myelodysplastic syndrome (MDS) who failed conventional therapy.

Duong VH, Jaglal MV, Zhang L, Kale V, Lancet JE, Komrokji RS, List AF. Duong VH, et al. Leuk Res. 2013 Mar;37(3):300-4. doi: 10.1016/j.leukres.2012.11.001. Epub 2012 Dec 27. Leuk Res. 2013. PMID: 23273539 Clinical Trial.

4

Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification models.

Duong VH, Lancet JE, Alrawi E, Al-Ali NH, Perkins J, Field T, Epling-Burnette PK, Zhang L, List AF, Komrokji RS. Duong VH, et al. Leuk Res. 2013 May;37(5):510-5. doi: 10.1016/j.leukres.2012.12.012. Epub 2013 Jan 16. Leuk Res. 2013. PMID: 23332452 Clinical Trial.

5

Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion.

Duong VH, Komrokji RS, List AF. Duong VH, et al. Ther Adv Hematol. 2012 Apr;3(2):105-16. doi: 10.1177/2040620711435659. Ther Adv Hematol. 2012. PMID: 23556117 Free PMC article.

6

Poor outcome of patients with myelodysplastic syndrome after azacitidine treatment failure.

Duong VH, Lin K, Reljic T, Kumar A, Al Ali NH, Lancet JE, List AF, Komrokji RS. Duong VH, et al. Clin Lymphoma Myeloma Leuk. 2013 Dec;13(6):711-5. doi: 10.1016/j.clml.2013.07.007. Epub 2013 Sep 17. Clin Lymphoma Myeloma Leuk. 2013. PMID: 24054159

7

Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice?

Duong VH, Padron E, List AF, Komrokji RS. Duong VH, et al. Expert Rev Hematol. 2013 Oct;6(5):485-7. doi: 10.1586/17474086.2013.827884. Epub 2013 Oct 2. Expert Rev Hematol. 2013. PMID: 24083503 No abstract available.

8

Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy.

Bhatnagar B, Duong VH, Gourdin TS, Tidwell ML, Chen C, Ning Y, Emadi A, Sausville EA, Baer MR. Bhatnagar B, et al. Among authors: duong vh. Leuk Lymphoma. 2014 Jul;55(7):1533-7. doi: 10.3109/10428194.2013.856425. Epub 2014 Feb 4. Leuk Lymphoma. 2014. PMID: 24144313

9

The role of pacritinib in the management of myelofibrosis.

Duong VH, Komrokji RS. Duong VH, et al. Expert Rev Hematol. 2014 Jun;7(3):325-32. doi: 10.1586/17474086.2014.905200. Epub 2014 Apr 21. Expert Rev Hematol. 2014. PMID: 24746271

10

Update on the pharmacotherapy for myelodysplastic syndromes.

Duong VH, Komrokji RS, List AF. Duong VH, et al. Expert Opin Pharmacother. 2014 Sep;15(13):1811-25. doi: 10.1517/14656566.2014.937705. Epub 2014 Jul 31. Expert Opin Pharmacother. 2014. PMID: 25080144 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters